Today's Reuters Health News Headlines - Yahoo! News:
|
|
K-V Pharmaceutical files for bankruptcy protection
Sat,4 Aug 2012 12:33 PM PDT
Reuters - CHICAGO (Reuters) - K-V Pharmaceutical, a Bridgeton-Missouri based company focused on women's healthcare products, filed for bankruptcy protection on Saturday, blaming federal actions that kept it from getting "full value" of a drug aimed at preventing premature births. The company, founded in 1942, listed debts of $728.3 million and assets of $236.6 million in a filing in bankruptcy court in New York. ... Full Story | Top |
Bayer eyes higher dividend: CFO in paper
Sat,4 Aug 2012 06:26 AM PDT
Reuters -  FRANKFURT (Reuters) - The finance chief of Bayer, Germany's largest drugmaker, raised the prospect of a dividend increase next year, following a higher profit outlook issued last month. "Our operating business is developing very well at the moment," Chief Financial Officer Werner Baumann told Sunday paper Frankfurter Allgemeine Sonntagszeitung in an interview, according to an excerpt made available to Reuters on Saturday. "Our last dividend was 1.65 euros per share. If adjusted earnings gain 10 percent as planned, we will have leeway for an increase. ...
Full Story | Top |
Some Ugandan Ebola patients likely to survive: doctors
Sat,4 Aug 2012 03:51 AM PDT
Reuters -  KAMPALA (Reuters) - Some of the 32 Ebola patients in isolation at a government hospital in western Uganda's Kibaale district are responding to treatment and may be discharged soon, a health official said on Friday. The east African country has been battling an outbreak of the deadly Ebola virus which has so far killed 16 people. Health officer Dan Kyamanywa said on Friday there had been no new deaths in two days. "There are signs of optimism because a big number of the 32 patients we have in isolation are recovering. ...
Full Story | Top |
U.S. to resume beef imports from Japan after two-year ban
Fri,3 Aug 2012 11:36 PM PDT
Reuters - TOKYO (Reuters) - The United States will restart importing beef from Japan this month, ending a two-year suspension imposed after foot-and-mouth disease was found in Japanese cows, the farm ministry in Tokyo said. Imports into the U.S., which were halted in April 2010 after the discovery of Japanese cows infected with the virus, will resume on August 17, Japan's farm ministry said in a statement released on Friday. "The United States (will) resume imports from Japan from August 17 onwards, acknowledging that (Japan) is clean from foot-and-mouth disease," the ministry said. ... Full Story | Top |
Pigs under scrutiny at Midwest state fairs after flu outbreak
Fri,3 Aug 2012 04:42 PM PDT
Reuters -  COLUMBUS, Ohio (Reuters) - People flocking to agricultural fairs across the United States were warned on Friday to be cautious around pigs after reports this week of nearly a dozen swine flu cases linked to attendance at fairs where sick pigs were present. Ten new cases of influenza A (H3N2) variant were reported in Ohio and one in Indiana associated with attendance at agricultural fairs. Another case was reported from Hawaii. ...
Full Story | Top |
Kids who drink soda may not drop milk
Fri,3 Aug 2012 03:44 PM PDT
Reuters -  NEW YORK (Reuters Health) - Kids who drink sugary beverages are not necessarily switching to them and away from milk, according to a new study whose results contradict earlier evidence that sodas and other sweetened drinks are displacing more nutritious ones in kids' diets. Instead, based on surveys of more than 7,000 middle-schoolers, researchers found that some kids may drink less milk as they grow older, but their consumption of soda and other sweetened drinks remains fairly steady. Sugary drink intake did not appear to be rising to replace milk. ...
Full Story | Top |
FDA to review Medivation, Astellas' prostate cancer drug in November
Fri,3 Aug 2012 03:36 PM PDT
Reuters -  (Reuters) - Medivation Inc and Japanese partner Astellas Pharma Inc said the U.S. health regulator has set an action date of November 22 to review the companies' marketing application for their experimental prostate cancer drug. Codenamed MDV3100, the drug is designed to treat men with castration-resistant prostate cancer for whom chemotherapy has failed. The U.S. Food and Drug Administration last month granted the drug a priority review, a designation given to expedite the review of treatments that aim to cure serious diseases and fill unmet medical needs. ...
Full Story | Top |
FDA approves Sanofi/Regeneron colon cancer drug
Fri,3 Aug 2012 03:19 PM PDT
Reuters -  (Reuters) - The U.S. Food and Drug Administration said on Friday that it had approved the Sanofi SA and Regeneron Pharmaceuticals Inc drug Zaltrap for patients with metastatic colorectal cancer whose tumors have failed to respond to earlier treatment with chemotherapy. The infused medicine, to be taken in combination with standard chemotherapy, will compete with Roche Holding AG's Avastin and Bristol-Myers Squibb Co's Erbitux. Industry analysts say they expect Zaltrap to win peak annual sales of perhaps $300 million to $400 million, well below the widely used older treatments. ...
Full Story | Top |
Thousands to be tested for hepatitis C in New Hampshire
Fri,3 Aug 2012 01:37 PM PDT
Reuters - BOSTON (Reuters) - Thousands of former patients at a New Hampshire hospital have been given permission to be tested to discover whether they were infected with the hepatitis C virus by a medical technician charged with stealing drugs and contaminating needles. The New Hampshire Department of Health and Human Services on Friday announced plans for testing about 3,300 former patients of Exeter Hospital who may have been infected. Any patient treated in the hospital's main operating rooms or intensive care unit between April 1, 2011 and May 25, 2012 may be at risk of infection. ... Full Story | Top |
U.S. FDA approves generic versions of Merck's Singulair
Fri,3 Aug 2012 01:13 PM PDT
Reuters -  WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday said it granted 10 drugmakers marketing approvals for the first generic forms of Singulair, the $5 billion-a-year asthma and allergy drug that is Merck & Co Inc's best-selling product. The drugmakers, whose cheaper versions of Singulair are expected to quickly steal two thirds of the branded product's sales, include Mylan Inc, Teva Pharmaceutical Industries Ltd and the Sandoz division of Novartis AG. ...
Full Story | Top |
CPR often leads to broken ribs
Fri,3 Aug 2012 01:02 PM PDT
Reuters -  NEW YORK (Reuters Health) - A significant portion of the people who receive cardiopulmonary resuscitation may end up with broken ribs or other bones as a result, according to Korean researchers, who also found that some types of patients could be at higher risk than others. In a study of people admitted to Korean hospitals, close to one third of those resuscitated after having CPR ended up with at least one broken rib, while about four percent had a broken breast bone, or sternum. Dr. ...
Full Story | Top |
How Elton John redeemed self from 'disgusting' past
Fri,3 Aug 2012 12:35 PM PDT
Reuters -  WASHINGTON (Reuters) - More than 20 years ago singer-songwriter Elton John was, by his own admission, living a disgusting life of self-pity and drug abuse. Then he met Ryan White. White was an American teenager who in 1984 contracted the virus that causes AIDS through a blood transfusion due to his hemophilia. He was expelled from school because of fear of the disease and became a vocal advocate of HIV/AIDS awareness and prevention. ...
Full Story | Top |
Talon future hinges on FDA chemotherapy decision
Fri,3 Aug 2012 12:14 PM PDT
Reuters - (Reuters) - Talon Therapeutics Inc, largely backed by venture capital, is banking on U.S. regulatory approval for its version of a nearly 50-year-old chemotherapy drug, which it expects will open the door to new licensing deals. The Food and Drug Administration is set to decide by August 12 on Talon's application for Marqibo for treating certain adults with acute lymphoblastic leukemia (ALL) who have failed at least two other therapies. ... Full Story | Top |
More minority women die in childbirth
Fri,3 Aug 2012 11:56 AM PDT
Reuters - NEW YORK (Reuters Health) - Minority women in the United States are more likely to die during or soon after childbirth than white women, according to a new study from the Centers for Disease Control and Prevention. Black, Hispanic and Asian women - and a handful of white women not born in the U.S. - accounted for 41 percent of all births nationwide between 1993 and 2006, but for 62 percent of pregnancy-related deaths, researchers found. "Everyone thinks the U.S. has great healthcare, which is definitely the case, but certainly there are populations in the U.S. ... Full Story | Top |
U.S. woman's altruism starts chain of five kidney swaps, extending lives
Fri,3 Aug 2012 11:20 AM PDT
Reuters -  NEW YORK (Reuters) - A soon-to-be wed gay couple, a retired teacher and his wife, and two pairs of fathers and sons were among those whose lives were changed one extraordinary day this week when a 35-year-old single mother of four from North Carolina donated a kidney to a stranger in New York. "I'm not losing nothing," Honica Brittman said this week, sitting in a blue and white hospital gown before surgery in which she would give, for free, the initial kidney in a chain of five kidney transplants at the New York-Presbyterian Hospital/Columbia University Medical Center. ...
Full Story | Top |
| |
|
No comments:
Post a Comment